During a volatile period for the cannabis market, a few under the radar stocks shined. The market hasn’t really noticed with a general …
HEXO’s (HEXO) latest earnings report did nothing to assuage concerns over the near term growth prospects of the company, as losses continue to …
The Canadian cannabis stocks continue to trade near the yearly lows and the Cannabis 2.0 rollout can’t start soon enough.
Near the end of November 2019 Aurora Cannabis (ACB) found it would no longer be able to sell medical cannabis to the German …
Despite the promising launch of Cannabis 2.0 products next week, a stock like HEXO (HEXO) still trades at yearly lows down 75% from …
The major benefit to U.S.
A big thesis of the Canadian cannabis LPs investment story was global expansion. The news last week of Aurora Cannabis (ACB) being blocked …
The FDA recently sent 15 warning letters to privately held companies concerning violations surrounding the inclusion of CBD in human and animal drugs, …
While the cannabis sector faces capital concerns, Aphria (APHA) was just able to secure a reasonably priced financing. The move possibly changes the …
There has been a lot of hype concerning what has been dubbed Cannabis 2.0 in Canada, as the country legalized a variety of …
